Definitive Healthcare Reports $241.5M Revenue for Fiscal Year 2025, Net Loss Reduced

Definitive Healthcare Corp. reported a revenue of $241.5 million for the fiscal year ending December 31, 2025, reflecting a decrease of 4% from $252.2 million in 2024. The decline was primarily attributed to a $12.7 million drop in subscription revenue, which was partially offset by a $2 million increase in professional services revenue. The company noted that revenue from existing customers decreased by $33.7 million, while new customer revenue increased by $23 million, including contributions from a recently launched data partnership. The net loss for the year was $199.3 million, a reduction from a loss of $591.4 million in the previous year, largely due to lower goodwill impairment charges.

In terms of operational metrics, Definitive Healthcare's customer base stood at approximately 2,330 as of December 31, 2025, down from 2,500 in 2024. The number of Enterprise Customers, defined as those generating over $100,000 in annual recurring revenue, decreased from 519 to 511. The company's Net Dollar Retention Rate (NDR) for Enterprise Customers fell to 85% from 90% in the prior year, indicating challenges in customer retention and upselling amid ongoing macroeconomic pressures. The company has identified over 100,000 potential customers in the healthcare ecosystem, suggesting significant growth opportunities despite current challenges.

Strategically, Definitive Healthcare has made several acquisitions, including the purchase of Populi for $54.1 million and the acquisition of Carevoyance for $13.7 million. These acquisitions are aimed at enhancing the company's data and analytics capabilities. However, the company has also faced restructuring challenges, implementing a plan that resulted in a workforce reduction of approximately 150 employees to improve operating margins. This restructuring has initially disrupted sales efforts, impacting both new customer acquisition and upselling to existing customers.

Looking ahead, Definitive Healthcare anticipates continued revenue challenges in 2026 due to macroeconomic conditions that have elongated deal cycles and increased customer churn, particularly among smaller clients. The company has also noted that its gross profit margins are expected to decline as a result of reduced revenue and the absence of one-time credits received in the previous year. Despite these challenges, there are signs of improvement in demand trends and customer retention dynamics, which the company plans to monitor closely as it navigates the evolving market landscape.